UNDER TRUMP, FDA SEEKS TO ABANDON EXPERT REVIEWS OF NEW DRUGS
https://assets3.cbsnewsstatic.com/hub/i/r/2025/09/12/2ae0b5d6-df54-40ad-92b4-7243e04f838d/thumbnail/1200x630/7cea9139b39fc73b71ef95a21168ff52/makary-fda.jpg
✍️ The FDA is considering abandoning its decades-old policy of asking outside experts to review drug applications, a move that critics say would shield the agency's decisions from public scrutiny.
👉 The FDA is considering abandoning its policy of asking outside experts to review drug applications 👉 Critics argue that this move would reduce transparency and accountability 👉 The FDA's advisory committees were created in 1972 to provide expert advice on drug approvals 👉 The move is seen as a way to consolidate power within the agency
-- #GeorgeTidmarsh #RobertCaliff #HollyFernandezLynch #MartyMakary #VinayPrasad #ReshmaRamachandran #PeterLurie #DianaZuckerman #GenevieveKanter #health
Loading quoted post…
